News
STAT+: In Duchenne muscular dystrophy, a promising therapy is available to a fortunate few
Exon-skipping drugs present a critical test for the FDA’s goal of encouraging treatments for rare disease.
More in Health
- ‘I thought the baby would change him’: the women whose pregnancies are blighted by domestic abuse The Guardian — Society
- 5 things civil rights data says about public schools NPR — Health
- Opinion: My oncologist recommended active surveillance for prostate cancer. Life insurers called it ‘untreated cancer’ STAT
- New global guidelines warn against obesity drugs for children under 10 BBC News — Health
- Dying Patients Are Inundated by Misinformation. My Dad Was One of Them. The New York Times — Health